1. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality 
Peter K Henke, MD, Susan Blackburn, MBA, Mary C Proctor, MS, Jeri Stevens, MS, Debabrata Mukherjee, MD, Sanjay Rajagopalin, MD, Gilbert R Upchurch, MD, James C Stanley, MD, Kim A Eagle, MD 
Journal of Vascular Surgery 
Volume 39, Issue 2, Pages (February 2004)
DOI: /j.jvs

2. Fig 1
Cardiovascular medication use in a population of patients undergoing infrainguinal bypass procedures over 5 years. AP, Antiplatelet therapy; AC, anticoagulant therapy; BB, β-blocker use; ACEI, angiotensin converting enzyme inhibitor use; MV, multivitamin.
Journal of Vascular Surgery  , DOI: ( /j.jvs )

3. Fig 2
Kaplan-Meier plot depicts overall survival over time. Dashed lines, 95% confidence intervals surrounding the main plot.
Journal of Vascular Surgery  , DOI: ( /j.jvs )

4. Fig 3
Kaplan-Meier plot compares survival in patients who were taking angiotensin converting enzyme inhibitors with those who were not taking this medication. The difference was significant by log-rank test, at P = .05. Dashed line, Portion of plot where standard error is greater than 10%.
Journal of Vascular Surgery  , DOI: ( /j.jvs )

5. Fig 4
Kaplan-Meier plot compares survival in patients who were taking aspirin with those who were not taking this medication. A trend was observed, but the difference did not reach significance (P = .067, log rank test). Dashed line, Portion of plot where standard error is greater than 10%.
Journal of Vascular Surgery  , DOI: ( /j.jvs )